Back to
Professor Morteza Aghmesheh

Professor Morteza Aghmesheh

Conjoint Senior Lecturer

  • 2024 – Australian Clinical Entrepreneur Program (AUSCEP) (2023–2024) 

  • 2008 – FRACP (Medical Oncology), Sydney, Australia 

  • 2003 – PhD (Cancer Genetics), UNSW & Prince of Wales Hospital, Sydney 

  • Research partly undertaken at the Department of Gynaecological Oncology and Anatomical Pathology, Norwegian Radium Hospital, Oslo, Norway 

  • 1998 – Graduate Diploma in Molecular Genetics, UNSW, Sydney 

  • 1994 – MD, Isfahan University of Medical Sciences, Iran 

Medicine & Health
School of Clinical Medicine
  • Journal articles | 2026
    Minaei E; Wade SJ; Penney C; Ranson M; Aghmesheh M; Sluyter R; Vine-Perrow KL, 2026, 'Localized Delivery of Anti-CD40/PD-1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a PDAC Mouse Model', Advanced Healthcare Materials, 15, http://dx.doi.org/10.1002/adhm.202503780
    Journal articles | 2026
    Wade SJ; Kumar AA; Nitschke SO; Joyce P; Minaei E; Reuter Lange SE; Penney C; Warren H; Shepherd R; Dinoro JN; Wallace GG; Dosseto A; Ansar S; Islam N; Lochhead A; Sharbeen G; Phillips PA; Aghmesheh M; Hawthorne WJ; Vine-Perrow KL, 2026, 'Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy', Advanced Materials, http://dx.doi.org/10.1002/adma.202522617
    Journal articles | 2026
    Wade SJ; Minaei E; Hope A; Turner RJ; Penney C; Beavis PA; Lai J; Wallace GG; Ansar S; Islam N; Lochhead A; Brungs D; Aghmesheh M; Vine-Perrow KL, 2026, 'Implantable drug delivery system improves tolerability of anti-CD40/anti-PD1 and chemotherapy in a murine model of breast cancer', European Journal of Pharmaceutical Sciences, 216, http://dx.doi.org/10.1016/j.ejps.2025.107359
    Journal articles | 2025
    Day D; Ganju V; Chung K; Si L; Mao L; Aghmesheh M; Hoyer R; Brewin K; Zeng S; Zhang M; Lu Q; Jiang C; Ren F; Zhu Y; Guo J, 2025, 'First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors: Clinical Studies', British Journal of Cancer, 132, pp. 905 - 912, http://dx.doi.org/10.1038/s41416-025-02990-x
    Journal articles | 2025
    Minaei E; Joyce P; Wade SJ; Brownlee C; Penney C; Ranson M; Aghmesheh M; Sluyter R; Vine-Perrow KL, 2025, 'Gut microbial diversity is preserved through localised chemo-immunotherapy delivery in a KPC mouse model of pancreatic cancer', Journal of Controlled Release, 386, http://dx.doi.org/10.1016/j.jconrel.2025.114143
    Journal articles | 2025
    Tie J; Wang Y; Loree JM; Cohen JD; Wong R; Price T; Tebbutt NC; Gebski V; Espinoza D; Burge M; Harris S; Lynam J; Lee B; Lee MM; Breadner D; Debrincat M; Foroughi S; Chantrill L; Lim SH; Gill S; O’Callaghan C; Ptak J; Silliman N; Dobbyn L; Popoli M; Bettegowda C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P; Kavan P; Burkes R; Armstrong D; Babak S; Shim K; Michael J; Ahmed S; Arif S; McGhie J; Tang P; Sideris L; Wong R; Zurawska U; Martel S; Samimi S; Chen E; Hubay S; Rask S; Goffin J; Kassam S; Mussawar I; Gotfrit J; Roitman D; Batra A; Yelamanchili R; Jeffery M; Karanth N; Wuttke M; Khattak A; Price T; Karapetis C; Karki B; Poursoltan P; Underhill C; Lum C; Barnett M; Karikios D; Wong M; Rai S; Srivastav R; Diakos C; Ng W; Beale P; Roohullah A; Begbie S; Aghmesheh M; Steel S; Saqib A; Chong G; Wong ZW; Lundy J; Hayes T; Singh M; McLachlan SA, 2025, 'Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial', Nature Medicine, 31, pp. 4291 - 4300, http://dx.doi.org/10.1038/s41591-025-04030-w
    Journal articles | 2024
    Bishnoi S; Kotasek D; Aghmesheh M; Yau T; Cosman R; Prawira A; Moore M; Chan SL; Mant A; Eek R; Zielinski R; Su R; Pan Z; Ma Y; Li F; Li P; Tse AN, 2024, 'Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study', Cancer, 130, pp. 1991 - 2002, http://dx.doi.org/10.1002/cncr.35226
    Journal articles | 2024
    Grimison P; Mersiades A; Kirby A; Tognela A; Olver I; Morton RL; Haber P; Walsh A; Lee Y; Abdi E; Della-Fiorentina S; Aghmesheh M; Fox P; Briscoe K; Sanmugarajah J; Marx G; Kichenadasse G; Wheeler H; Chan M; Shannon J; Gedye C; Begbie S; Simes RJ; Stockler MR, 2024, 'Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial', Journal of Clinical Oncology, 42, pp. 4040 - 4050, http://dx.doi.org/10.1200/JCO.23.01836
    Journal articles | 2024
    Lim AHW; Singhal N; Bartholomeusz D; Zobel J; Naidu J; Hsieh W; Crouch B; Wasan H; Croagh D; Nagrial A; Aghmesheh M; Tse E; Rayner CK; Nguyen NQ, 2024, 'Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma', Igie, 3, pp. 373 - 381, http://dx.doi.org/10.1016/j.igie.2024.06.005
    Journal articles | 2024
    Minaei E; Ranson M; Aghmesheh M; Sluyter R; Vine KL, 2024, 'Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds', Journal of Controlled Release, 373, pp. 145 - 160, http://dx.doi.org/10.1016/j.jconrel.2024.07.023
    Journal articles | 2023
    Haggstrom LR; Tucker K; Williams R; Nelson A; Walsh R; Brungs D; Aghmesheh M, 2023, 'Exceptional Response to Olaparib: A Case Report of Metastatic Esophageal Squamous Cell Carcinoma in a Patient with Fanconi Anemia, Germline FANCA Mutation, and Somatic BRCA2 Mutations', JCO Precision Oncology, 7, http://dx.doi.org/10.1200/PO.23.00221
    Journal articles | 2023
    Mersiades A; Kirby A; Stockler MR; Tognela A; Olver IN; Morton RL; Haber P; Walsh A; Lee Y; Abdi EA; Della-Fiorentina S; Aghmesheh M; Fox P; Briscoe KP; Sanmugarajah J; Marx GM; Kichenadasse G; Wheeler H; Simes J; Grimison PS, 2023, 'Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial.', JOURNAL OF CLINICAL ONCOLOGY, 41, pp. 12019 - 12019, http://dx.doi.org/10.1200/JCO.2023.41.16_suppl.12019
    Journal articles | 2023
    Symons R; Daly D; Gandy R; Goldstein D; Aghmesheh M, 2023, 'Progress in the Treatment of Small Intestine Cancer', Current Treatment Options in Oncology, 24, pp. 241 - 261, http://dx.doi.org/10.1007/s11864-023-01058-3
    Journal articles | 2023
    Turner RJ; Guy TV; Geraghty NJ; Splitt A; Watson D; Brungs D; Carolan MG; Miller AA; de Leon JF; Aghmesheh M; Sluyter R, 2023, 'Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms241612538
    Journal articles | 2023
    Yeo N; Genenger B; Aghmesheh M; Thind A; Napaki S; Perry J; Ashford B; Ranson M; Brungs D, 2023, 'Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma', Cancers, 15, http://dx.doi.org/10.3390/cancers15205026
    Journal articles | 2022
    Hope A; Wade SJ; Aghmesheh M; Vine KL, 2022, 'Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment', Journal of Controlled Release, 341, pp. 399 - 413, http://dx.doi.org/10.1016/j.jconrel.2021.11.043
    Journal articles | 2022
    Ross PJ; Wasan HS; Croagh D; Nikfarjam M; Nguyen N; Aghmesheh M; Nagrial AM; Bartholomeusz D; Hendlisz A; Ajithkumar T; Iwuji C; Wilson NE; Turner DM; James DC; Young E; Harris MT, 2022, 'Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy', ESMO Open, 7, http://dx.doi.org/10.1016/j.esmoop.2021.100356
    Journal articles | 2022
    Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia Pacific Journal of Clinical Oncology, 18, pp. 660 - 668, http://dx.doi.org/10.1111/ajco.13745
    Journal articles | 2022
    Tincknell G; Naveed A; Nankervis J; Mukhtiar A; Piper AK; Becker TM; Chantrill L; Aghmesheh M; Vine KL; Ranson M; Brungs D, 2022, 'HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis', Cancers, 14, http://dx.doi.org/10.3390/cancers14235754
    Journal articles | 2022
    Wai Siu DH; O'Neill RS; Harris CA; Wang J; Ardolino L; Downton T; Tong M; Hong JH; Chin V; Clingan PR; Aghmesheh M; Soudy H, 2022, 'Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review', Immunotherapy, 14, pp. 511 - 520, http://dx.doi.org/10.2217/imt-2021-0225
    Journal articles | 2022
    Woodford R; Brungs D; Leighton C; Grimison P; Sjoquist KM; Becker T; Robinson S; Gebski V; Wilson K; Chantrill L; Aghmesheh M, 2022, 'Combination chemotherapy with NAB®-paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP-CAPABIL Pilot Study)', Asia Pacific Journal of Clinical Oncology, 18, pp. e220 - e226, http://dx.doi.org/10.1111/ajco.13599
    Journal articles | 2021
    Tincknell G; Piper AK; Aghmesheh M; Becker T; Vine KL; Brungs D; Ranson M, 2021, 'Experimental and clinical evidence supports the use of urokinase plasminogen activation system components as clinically relevant biomarkers in gastroesophageal adenocarcinoma', Cancers, 13, http://dx.doi.org/10.3390/cancers13164097
    Journal articles | 2020
    Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Samra JS; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Donoghoe M; Goldstone S; Yip S; Pavlakis N; Aghmesheh M; Joubert W; Grimes D; Bagia S; Jaber M; Bryant R; Nathanson L; Cavallucci D; Fawcett J; O’Rourke T; Croagh D; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2
    Journal articles | 2020
    Brungs D; Minaei E; Piper AK; Perry J; Splitt A; Carolan M; Ryan S; Wu XJ; Corde S; Tehei M; Aghmesheh M; Vine KL; Becker TM; Ranson M, 2020, 'Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-019-57164-6
    Journal articles | 2020
    Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M, 2020, 'Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial', Annals of Oncology, 31, pp. 1553 - 1560, http://dx.doi.org/10.1016/j.annonc.2020.07.020
    Journal articles | 2020
    Haggstrom L; Kang S; Winn R; Putnis S; Nasser E; Chen J; Aghmesheh M; Brungs D, 2020, 'Factors influencing recurrence of stage I–III rectal cancer in regional Australia', ANZ Journal of Surgery, 90, pp. 2490 - 2495, http://dx.doi.org/10.1111/ans.16187
    Journal articles | 2020
    Juszczyk K; Kang S; Putnis S; Winn R; Chen J; Aghmesheh M; Fylyk G; Brungs D, 2020, 'High body mass index is associated with an increased overall survival in rectal cancer', Journal of Gastrointestinal Oncology, 11, pp. 626 - 632, http://dx.doi.org/10.21037/jgo-20-48
    Journal articles | 2020
    Wade SJ; Sahin Z; Piper AK; Talebian S; Aghmesheh M; Foroughi J; Wallace GG; Moulton SE; Vine KL, 2020, 'Dual Delivery of Gemcitabine and Paclitaxel by Wet-Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation', Advanced Healthcare Materials, 9, http://dx.doi.org/10.1002/adhm.202001115
    Journal articles | 2019
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2019, 'Chemotherapy-induced fatigue estimation using hidden Markov model', Biocybernetics and Biomedical Engineering, 39, pp. 176 - 187, http://dx.doi.org/10.1016/j.bbe.2018.11.002
    Journal articles | 2019
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2019, 'Quantitative and non-invasive measurement of exercise-induced fatigue', Proceedings of the Institution of Mechanical Engineers Part P Journal of Sports Engineering and Technology, 233, pp. 34 - 45, http://dx.doi.org/10.1177/1754337118775548
    Journal articles | 2019
    Brungs D; Lochhead A; Iyer A; Illemann M; Colligan P; Hirst NG; Splitt A; Liauw W; Vine KL; Pathmanandavel S; Carolan M; Becker TM; Aghmesheh M; Ranson M, 2019, 'Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma', Pathology, 51, pp. 474 - 480, http://dx.doi.org/10.1016/j.pathol.2019.03.009
    Journal articles | 2019
    Clingan PR; Ackland SP; Brungs D; de Souza P; Aghmesheh M; Garg MB; Ranson RD; Parker S; Jokela R; Ranson M, 2019, 'First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment', Asia Pacific Journal of Clinical Oncology, 15, pp. 151 - 157, http://dx.doi.org/10.1111/ajco.13144
    Journal articles | 2019
    Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn MJ; Soria A; Machiels JP; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ; Acosta-Rivera M; Adkins DR; Aghmesheh M; Airoldi M; Aleknavicius E; Al-Farhat Y; Algazi AP; Almokadem S; Alyasova A; Bauman JR; Benasso M; Berrocal A; Bray V; Caponigro F; Castro A; Cescon TP; Chan K; Chaudhry A; Chauffert B; Cohen E; Csoszi T; De Boer JP; Delord JP; Dietz A; Dupuis C; Digue L; Erfan J; Escobar Alvarez Y; Evans M; Fidler MJ; Forster MD; Friesland S; Ganti AK; Geoffrois L; Grant C; Gruenwald V; Hoffmann T; Horvai G; Inciura A; Jang R; Jankowska P; Jimeno A; Joseph M; Juarez Ramiro A; Karaszewska B; Kawecki A; Keilholz U; Keller U; Kim SB; Kocsis J; Kotecki N; Kozloff MF; Lambea J; Landherr L; Lantsukhay Y; Lazarev SA; Lee LW; Lifirenko ID; Martincic D; Matorin OV; McGrath M; Misiukiewicz K; Morris JC; Mufazalov FF; Niu J; Pamoorthy Srinivasan D; Perez Segura P; Rauch D; Ribeiro ML; Rodriguez C; Rolland F; Russo A; Ruzsa A; Sanches F; Shin SW; Shtiveland M; Specenier P; Szekanecz E; Szota J; van Herpen CML; Velez-Cortes HA; Walsh WV, 2019, 'Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study', Lancet, 393, pp. 156 - 167, http://dx.doi.org/10.1016/S0140-6736(18)31999-8
    Journal articles | 2019
    Haggstrom L; Duong TA; Thomas B; Brungs D; Aghmesheh M; Parmar G, 2019, 'Disseminated intravascular coagulation and melanoma: A novel case occurring in metastatic melanoma with BRAF and NRAS mutations and systematic review', Melanoma Research, 29, pp. 533 - 538, http://dx.doi.org/10.1097/CMR.0000000000000622
    Journal articles | 2019
    Li A; Geyer FC; Blecua P; Lee JY; Selenica P; Brown DN; Pareja F; Lee SSK; Kumar R; Rivera B; Bi R; Piscuoglio S; Wen HY; Lozada JR; Gularte-Mérida R; Cavallone L; Aghmesheh M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Blackburn A; Bogwitz M; Brown M; Burgess M; Burke J; Butow P; Caldon L; Campbell I; Christian A; Clarke C; Cohen P; Crook A; Cui J; Cummings M; Dawson SJ; De Fazio A; Delatycki M; Dobrovic A; Dudding T; Duijf P; Edkins E; Edwards S; Farshid G; Fellows A; Field M; Flanagan J; Fong P; Forbes J; Forrest L; Fox S; French J; Friedlander M; Ortega DG; Gattas M; Giles G; Gill G; Gleeson M; Greening S; Haan E; Harris M; Hayward N; Hickie I; Hopper J; Hunt C; James P; Jenkins M; Kefford R; Kentwell M; Kirk J; Kollias J; Lakhani S; Lindeman G; Lipton L; Lobb L; Lok S; Macrea F; Mann G; Marsh D; McLachlan SA; Meiser B; Milne R; Nightingale S; O’Connell S; Pachter N; Patterson B; Phillips K; Saleh M; Salisbury E; Saunders C; Saunus J; Scott C; Scott R; Sexton A; Shelling A; Simpson P; Spigelman A; Spurdle M; Stone J, 2019, 'Homologous recombination DNA repair defects in PALB2-associated breast cancers', Npj Breast Cancer, 5, http://dx.doi.org/10.1038/s41523-019-0115-9
    Journal articles | 2019
    Li A; Geyer FC; Blecua P; Lee JY; Selenica P; Brown DN; Pareja F; Lee SSK; Kumar R; Rivera B; Bi R; Piscuoglio S; Wen HY; Lozada JR; Gularte-Mérida R; Cavallone L; Aghmesheh M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Blackburn A; Bogwitz M; Brown M; Burgess M; Burke J; Butow P; Caldon L; Campbell I; Christian A; Clarke C; Cohen P; Crook A; Cui J; Cummings M; Dawson SJ; De Fazio A; Delatycki M; Dobrovic A; Dudding T; Duijf P; Edkins E; Edwards S; Farshid G; Fellows A; Field M; Flanagan J; Fong P; Forbes J; Forrest L; Fox S; French J; Friedlander M; Ortega DG; Gattas M; Giles G; Gill G; Gleeson M; Greening S; Haan E; Harris M; Hayward N; Hickie I; Hopper J; Hunt C; James P; Jenkins M; Kefford R; Kentwell M; Kirk J; Kollias J; Lakhani S; Lindeman G; Lipton L; Lobb L; Lok S; Macrea F; Mann G; Marsh D; McLachlan SA; Meiser B; Milne R; Nightingale S; O’Connell S; Pachter N; Patterson B; Phillips K; Saleh M; Salisbury E; Saunders C; Saunus J; Scott C; Scott R; Sexton A; Shelling A; Simpson P; Spigelman A; Spurdle M; Stone J, 2019, 'Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)', Npj Breast Cancer, 5, http://dx.doi.org/10.1038/s41523-019-0140-8
    Journal articles | 2019
    McCabe M; Gauthier M-E; Chan C-L; Thompson T; De Sousa S; Puttick C; Grady J; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas M; kConFab ; Lord R; Johns A; Kohonen-Corish M; O'Toole S; Clark J; Mueller S; Gupta R; McCormack A; Dinger M; Cowley M; Bastick P; Friedlander M; Colley A; Andrews L; Young M-A; Tucker K; Williams R; Aghmesheh M, 2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports, 9, pp. 17052, http://dx.doi.org/10.1038/s41598-019-52000-3
    Journal articles | 2018
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M, 2018, 'Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer', Clinical Colorectal Cancer, 17, pp. e549 - e555, http://dx.doi.org/10.1016/j.clcc.2018.05.004
    Journal articles | 2018
    Brungs D; Lynch D; Luk AWS; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; De Souza P; Becker TM, 2018, 'Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer', World Journal of Gastroenterology, 24, pp. 810 - 818, http://dx.doi.org/10.3748/wjg.v24.i7.810
    Journal articles | 2018
    Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P, 2018, 'Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)', BMJ Open, 8, http://dx.doi.org/10.1136/BMJOPEN-2017-020745
    Journal articles | 2017
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2017, 'Objective clinical gait analysis using inertial sensors and six minute walking test', Pattern Recognition, 63, pp. 246 - 257, http://dx.doi.org/10.1016/j.patcog.2016.08.002
    Journal articles | 2017
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M, 2017, 'Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin', Cell Communication and Signaling, 15, pp. 1 - 15, http://dx.doi.org/10.1186/s12964-017-0164-3
    Journal articles | 2017
    Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2017, 'Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review', Asia Pacific Journal of Clinical Oncology, 13, pp. e291 - e297, http://dx.doi.org/10.1111/ajco.12638
    Journal articles | 2017
    Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M, 2017, 'Sidedness is prognostic in locoregional colon cancer: An analysis of 9509 Australian patients', BMC Cancer, 17, pp. 251, http://dx.doi.org/10.1186/s12885-017-3255-z
    Journal articles | 2017
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M, 2017, 'The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis', Oncotarget, 8, pp. 23099 - 23109, http://dx.doi.org/10.18632/oncotarget.15485
    Journal articles | 2017
    Wade SJ; Zuzic A; Foroughi J; Talebian S; Aghmesheh M; Moulton SE; Vine KL, 2017, 'Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer', Pancreatology, 17, pp. 795 - 804, http://dx.doi.org/10.1016/j.pan.2017.06.001
    Journal articles | 2016
    Brungs D; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M, 2016, 'Gastric cancer stem cells: evidence, potential markers, and clinical implications', Journal of Gastroenterology, http://dx.doi.org/10.1007/s00535-015-1125-5
    Journal articles | 2016
    Ferraro D; Goldstein D; O'Connell RL; Zalcberg JR; Sjoquist KM; Tebbutt NC; Grimison P; McLachlan S; Lipton LL; Vasey P; Gebski VJ; Aiken C; Cronk M; Ng S; Karapetis CS; Shannon J; Do V; Marschner I; Friedlander M; Gurney H; Simes J; Hague W; O’Connell R; Gorzeman M; Pike R; Miranda K; Waring P; Lau D; Fox S; Liu Y; Wood T; Cocks C; Simmons K; McCourt J; Jefford M; Hobinchet A; Mirco B; Sagong J; Dudukovic S; Aghmesheh M; Parker S; Segelov E; Ratnayake L; Ranieri N; Varma S; Page J; Heyer E; Abdi E; Chorlton C; Wilkinson L; Marshall I, 2016, 'TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer', Cancer Chemotherapy and Pharmacology, 78, pp. 361 - 367, http://dx.doi.org/10.1007/s00280-016-3089-4
    Journal articles | 2016
    Pelttari LM; Khan S; Vuorela M; Kiiski JI; Vilske S; Nevanlinna V; Ranta S; Schleutker J; Winqvist R; Kallioniemi A; Dörk T; Bogdanova NV; Figueroa J; Pharoah PDP; Schmidt MK; Dunning AM; García-Closas M; Bolla MK; Dennis J; Michailidou K; Wang Q; Hopper JL; Southey MC; Rosenberg EH; Fasching PA; Beckmann MW; Peto J; Dos-Santos-silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Surowy H; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; Benitez J; González-Neira A; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Brüning T; Lindblom A; Margolin S; Mannermaa A; Hartikainen JM; Chenevix-Trench G; Van Dyck L; Janssen H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Hallberg E; Olson JE; Giles GG; Milne RL; Haiman CA; Schumacher F; Simard J; Dumont M; Kristensen V; Borresen-Dale AL; Zheng W; Beeghly-Fadiel A; Grip M; Andrulis IL; Glendon G; Devilee P; Seynaeve C; Hooning MJ; Collée M; Cox A; Cross SS; Shah M; Luben RN; Hamann U; Torres D; Jakubowska A; Lubinski J; Couch FJ; Yannoukakos D; Orr N; Swerdlow A; Darabi H; Li J; Czene K; Hall P; Easton DF; Mattson J; Blomqvist C; Aittomäki K; Nevanlinna H; Aghmesheh M; Amor D; Andrews L; Ward R; Friedlander M; Links M; Tucker K; Sayer R; Bastick P; Colley A; Underhill C, 2016, 'RAD51B in familial breast cancer', Plos One, 11, pp. e0153788, http://dx.doi.org/10.1371/journal.pone.0153788
    Journal articles | 2015
    Aghmesheh M; Saxena A; Niknam F, 2015, 'BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas', Asia Pacific Journal of Clinical Oncology, 11, pp. 135 - 141, http://dx.doi.org/10.1111/ajco.12310
    Journal articles | 2015
    Sobral-Leite M; Wesseling J; Smit VTHBM; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JHM; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JWM; van Deurzen CHM; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PDP; García-Closas M; de Graauw M; Schmidt MK; Aghmesheh M; Amor D; Andrews L; Antill Y; Armitage S; Arnold L; Balleine R; Bankier A; Bastick P; Beesley J; Beilby J; Bennett B; Bennett I; Berry G; Blackburn A; Bogwitz M; Brennan M; Brown M; Buckley M; Burgess M; Burke J; Butow P; Byron K; Callen D; Campbell I; Chauhan D; Chauhan M; Christian A; Clarke C; Colley A; Cotton D; Crook A; Cui J; Culling B; Cummings M; Dawson SJ; de Fazio A; Delatycki M; Dickson R; Dixon J; Dobrovic A; Dudding T; Edkins T; Edwards S; Eisenbruch M; Farshid G; Fawcett S; Fellows A; Fenton G; Field M; Firgaira F; Flanagan J; Fleming J; Fong P, 2015, 'Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis', BMC Medicine, 13, http://dx.doi.org/10.1186/s12916-015-0392-6
    Journal articles | 2011
    Elsokkari I; Napaki S; Greening S; Aghmesheh M, 2011, 'Primary transitional cell carcinoma of the fallopian tube.', Journal of Obstetrics and Gynaecology Research, 37, pp. 1767 - 1771, http://dx.doi.org/10.1111/j.1447-0756.2011.01604.x
    Journal articles | 2011
    Niknam F; Chen J; Napaki S; Aghmesheh M, 2011, 'Approach to multiple pulmonary nodules: A case report and review of literature', Thescientificworldjournal, 11, pp. 760 - 765, http://dx.doi.org/10.1100/tsw.2011.74
    Journal articles | 2009
    Links M; Aghmesheh M, 2009, 'Second opinions: Agendas and ego', Acta Oncologica, 48, pp. 1210 - 1213, http://dx.doi.org/10.3109/02841860902896105
    Journal articles | 2006
    Aghmesheh M; Suo Z; Friedlander ML; Nesland J; Kaern J; Stewart MP; Dorum A; Tucker K; Buckley MF, 2006, 'Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas', Pathology, 38, pp. 145 - 151
    Journal articles | 2005
    Aghmesheh M; Edwards LS; Clarke CL; Byth K; Katzenellenbogen B; Russell PJ; Friedlander ML; Tucker K; de Fazio A, 2005, 'Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas', Gynecologic Oncology, 97, pp. 16 - 25, http://www.sciencedirect.com/science/article/B6WG6-4FDMYCP-5/2/f127ac58f5e70d17372bc0c7d403bfc7
    Journal articles | 2005
    Kaern J; Aghmesheh M; Nesland JM; Danielsen HE; Sandstad B; Friedlander M; Tropé C, 2005, 'Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?', International Journal of Gynecological Cancer, 15, pp. 1014 - 1022, http://dx.doi.org/10.1136/ijgc-00009577-200511000-00003
    Journal articles | 2004
    Aghmesheh M; Nesland J; Kaern J; Dorum A; Edwards LS; Byth K; Friedlander ML; Jackson P; Tucker K; Russell PJ, 2004, 'No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers', Gynecologic Oncology, 95, pp. 430 - 436, http://www.sciencedirect.com/science/article/B6WG6-4DXB995-1/2/ed6c7284e0c7d1c30ad49018f2a9cb0d
    Journal articles | 2000
    Daja MM; Agmeshah M; Ow KT; Rohde PR; Russell PJ; Barrow KD, 2000, 'Beta-human chorionic gonadotrophin in Seven : marker for early Detection of prostate cancer?', Molecular Urology, pp. 421 - 427
  • Conference Papers | 2024
    Brungs D; Hill J; Aghmesheh M; Ackland SP; Parker S; Jokela RM; Garg MB; Reuter SE; Meola TR; Ranson M; Ranson RD; Toouli CD; Strange N; Clingan PR, 2024, 'A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment', in Journal of Clinical Oncology, http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.140
    Conference Papers | 2024
    Tie J; Cohen JD; Wang Y; Ginestet PG; Wong R; Shapiro JD; Campbell R; Day F; Hayes TM; Aghmesheh M; Karapetis CS; Popoli M; Dobbyn L; Ptak J; Silliman N; Douville CB; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2024, 'Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study', in Journal of Clinical Oncology, pp. 12 - 12, http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.12
    Conference Papers | 2024
    Wainberg ZA; Shiu KK; Rivera F; Medley LC; Aghmesheh M; Dunne RF; Roy R; Wyrwicz LS; Larson T; Metges JP; Mansoor W; Goekkurt E; Moreira Antunes LC; Castro Oliden V; Jensen E; Shah S; Bordia S; Bhagia P; Lowery MA, 2024, 'First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): Analysis of KEYNOTE-590 and KEYNOTE-859 by tumor type.', in Journal of Clinical Oncology, pp. 345 - 345, http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.345
    Conference Papers | 2017
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2017, 'Objective clinical functional assessment of breast cancer patients using inertial motion capture', in IEEE Region 10 Annual International Conference Proceedings TENCON, pp. 2935 - 2938, http://dx.doi.org/10.1109/TENCON.2016.7848582
    Conference Papers | 2017
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2017, 'Objective fatigue measurement through adaptive neuro-fuzzy inference system', in M2vip 2016 Proceedings of 23rd International Conference on Mechatronics and Machine Vision in Practice, http://dx.doi.org/10.1109/M2VIP.2016.7827300
    Conference Papers | 2016
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2016, 'Assessment of exercise induced fatigue through motion analysis', in IEEE Region 10 Annual International Conference Proceedings TENCON, http://dx.doi.org/10.1109/TENCON.2015.7372750
    Conference Abstracts | 2016
    Brungs D; Healey E; Rose J; Tubaro T; Ng W; Chua W; Carolan M; de Souza P; Aghmesheh M; Ranson M, 2016, 'Adjuvant chemotherapy for stage III colorectal cancer in the elderly', in Annals of Oncology, Vol. 27, pp. vi182, http://dx.doi.org/10.1093/annonc/mdw370.101
    Conference Papers | 2013
    Ameli S; Stirling D; Naghdy F; Naghdy G; Aghmesheh M, 2013, 'Assessing the impact of fatigue on gait using inertial sensors', in 2013 IEEE ASME International Conference on Advanced Intelligent Mechatronics Mechatronics for Human Wellbeing AIM 2013, pp. 307 - 312, http://dx.doi.org/10.1109/AIM.2013.6584109
    Conference Papers | 2012
    Ameli S; Naghdy F; Stirling D; Naghdy G; Aghmesheh M, 2012, 'Objective clinical fitness assessment using inertial sensors', in Procedia Engineering, pp. 443 - 449, http://dx.doi.org/10.1016/j.proeng.2012.07.196
    Conference Papers | 2002
    Aghmesheh M; Edwards L; Clarke CL; Russell PJ; Friedlander ML; Tucker K; Defazio A, 2002, 'Steroid hormone receptor expression in heriditary and sporadic ovarian cancers', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, Philadelphia, PA, USA, pp. 6 - 6, presented at 93rd Annual Meeting of the AACR, San Francisco, California USA, 06 April 2002 - 10 April 2002

2024–2028 – UNSW Ideas Grant 

  • Project Title: Personalising neoadjuvant therapy for early-stage, high-risk triple-negative breast cancer 

  • CIA: Jeff Holst | CIB: Kanu Wahi | CIC: Morteza Aghmesheh 

  • Funding: $1,421,151.20 | Application No.: 2037397 

2019–2021 – Cancer Australia Priority-Driven Collaborative Cancer Research Scheme 

  • Title: Implantable drug-eluting device for localised drug delivery in unresectable pancreatic cancer 

  • CIA: Kara Vine | CIB: Simon Moulton | CIC: Morteza Aghmesheh (clinical lead) 

  • Funding: $554,920 | Application No.: 1165978 

2020 – CONCERT ECR Grant 

  • Title: Localised Immunotherapy for Pancreatic Cancer: Targeting CD40 to enhance tumour immunity 

  • CI: Kara Vine | AI: Minoti Apte, Morteza Aghmesheh, Daniel Brungs, Lorraine Chantrill, Desmond Yip 

  • Funding: $100,000 

2019 – Breast Cancer Illawarra Grant 

  • Title: Local immunotherapy delivery via implantable device for triple-negative breast cancer 

  • CIA: Morteza Aghmesheh | CIB: Kara Perrow | CIC: Philip Clingan 

  • Funding: $58,000 

2015 – IHMRI Near-Miss Grant Scheme (NHMRC) 

  • Title: 3D dual-drug-eluting polymeric structures for neoadjuvant pancreatic cancer therapy 

  • CIA: Kara Vine | CIB: Morteza Aghmesheh 

  • Funding: $20,000 

Shape 

Philanthropic & Institutional Grants 

2025 – Donation from a family 

  • Purpose: Research in colorectal cancer at POWH/UNSW 

  • Responsible: Morteza Aghmesheh 

  • Fund: $50,000 

2023 – Illawarra Cancer Carers Grant 

  • Purpose: Equipment for Illawarra & Shoalhaven Cancer Biobank 

  • Applicant: Morteza Aghmesheh 

  • Funding: $56,000 

2017 – IHMRI Seeding Grant 

  • Title: Immune network analysis in HNSCC during chemoradiation 

  • CIA: Morteza Aghmesheh | CIB: Thomas Guy | CIC: Daniel Brungs | CID: Ronald Sluyter 

  • Funding: $25,000 

2017 – Illawarra Cancer Carers Grant 

  • Title: Animal study of implantable drug-eluting device for LAPC 

  • CIA: Morteza Aghmesheh | CIB: Kara Perrow | CIC: Samantha Wade 

  • Funding: $20,000 

2015 – Illawarra Cancer Carers Grant 

  • Title: Circulating Tumour Cells (CTCs) in early and advanced gastro-oesophageal cancers 

  • CIA: Kara Perrow | CIB: Daniel Brungs | CIC: Morteza Aghmesheh 

  • Funding: $20,000 

2014 – Illawarra Cancer Carers Fund 

  • Title: Purchasing a mobile ultrasound for chemotherapy unit at Illawarra cancer care centre 

  • Responsible: Morteza Aghmesheh 

  • Funding: $14,000